Matthew J. Tozer

1.6k total citations
34 papers, 1.3k citations indexed

About

Matthew J. Tozer is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Matthew J. Tozer has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 18 papers in Molecular Biology and 7 papers in Spectroscopy. Recurrent topics in Matthew J. Tozer's work include Receptor Mechanisms and Signaling (9 papers), Chemical Synthesis and Analysis (8 papers) and Neuropeptides and Animal Physiology (6 papers). Matthew J. Tozer is often cited by papers focused on Receptor Mechanisms and Signaling (9 papers), Chemical Synthesis and Analysis (8 papers) and Neuropeptides and Animal Physiology (6 papers). Matthew J. Tozer collaborates with scholars based in United Kingdom, United States and Australia. Matthew J. Tozer's co-authors include Susan E. Gibson, Nathalie Guillo, William B. Motherwell, Barry C. Ross, S. Barret Kalindjian, Michael J. Pether, Ian R. Greig, Ildiko M. Buck, Iain M. McDonald and A. L. J. BECKWITH and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Chemistry - A European Journal.

In The Last Decade

Matthew J. Tozer

34 papers receiving 1.2k citations

Peers

Matthew J. Tozer

SPECT

Thomas G. Gant United States

Christophe Génicot Belgium

Rajarathnam E. Reddy United States

Patrick Pasau Belgium

Florencio Zaragoza Denmark

Joseph J. Topczewski United States

Danielle Grée France

Francesco De Sarlo Italy

Mihirbaran Mandal United States

Daniel Zimmerli Switzerland

Thomas G. Gant United States

Matthew J. Tozer

972 ×1.0

465 ×0.9

325 ×0.7

384 ×2.2

136 ×1.1

SPECT

Citations per year, relative to Matthew J. Tozer Matthew J. Tozer (= 1×) peers Thomas G. Gant

Countries citing papers authored by Matthew J. Tozer

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Tozer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Tozer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Tozer more than expected).

Fields of papers citing papers by Matthew J. Tozer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Tozer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Tozer. The network helps show where Matthew J. Tozer may publish in the future.

Co-authorship network of co-authors of Matthew J. Tozer

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Tozer. A scholar is included among the top collaborators of Matthew J. Tozer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Tozer. Matthew J. Tozer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tozer, Matthew J., Karl R. Gibson, Paul A. Glossop, et al.. (2020). Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor. ACS Pharmacology & Translational Science. 3(4). 706–719. 13 indexed citations

Gibson, Susan E., David Hardick, Peter Haycock, et al.. (2007). A Study of (Binap)(enyne)tetracarbonyldicobalt(0) Complexes. Chemistry - A European Journal. 13(25). 7099–7109. 9 indexed citations

Tozer, Matthew J., et al.. (2002). ω-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 10(2). 425–432. 9 indexed citations

Gibson, Susan E., et al.. (2002). Synthesis and structural analysis of dehydrophenylalanine cyclophanes. Chemical Communications. 1938–1939. 9 indexed citations

Gibson, Susan E., et al.. (2002). CCK2 receptor antagonists containing the conformationally constrained phenylalanine derivatives, including the new amino acid Xic. European Journal of Medicinal Chemistry. 37(5). 379–389. 22 indexed citations

Kalindjian, S. Barret, Caroline M. R. Low, Michael J. Pether, et al.. (2001). Nonpeptide Cholecystokinin-2 Receptor Agonists. Journal of Medicinal Chemistry. 44(8). 1125–1133. 16 indexed citations

Greig, Ian R., et al.. (2001). Synthesis of Cyclic Sulfonamides through Intramolecular Diels−Alder Reactions. Organic Letters. 3(3). 369–371. 54 indexed citations

Tozer, Matthew J. & S. Barret Kalindjian. (2000). Histamine H₃receptor antagonists. Expert Opinion on Therapeutic Patents. 10(7). 1045–1055. 30 indexed citations

Tozer, Matthew J., et al.. (1999). 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: The design of potent histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(21). 3103–3108. 19 indexed citations

10.

Gibson, Susan E., et al.. (1999). A Bromoarene Based Approach to Phenylalanine Analogues Hic and Nic. Synlett. 1999(Sup. 1). 954–956. 15 indexed citations

11.

Gibson, Susan E., Nathalie Guillo, & Matthew J. Tozer. (1999). ChemInform Abstract: Towards Control of χ‐Space: Conformationally Constrained Analogues of Phe, Tyr, Trp, and His.. ChemInform. 30(23). 1 indexed citations

12.

Tozer, Matthew J., et al.. (1999). From histamine to imidazolylalkyl-sulfonamides: The design of a novel series of histamine H3-receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(13). 1825–1830. 15 indexed citations

13.

Gibson, Susan E., et al.. (1997). ChemInform Abstract: Synthesis of Conformationally Constrained Phenylalanine Analogues via 7‐, 8‐, and 9‐endo Heck Cyclizations.. ChemInform. 28(29). 1 indexed citations

14.

Gibson, Susan E., Nathalie Guillo, & Matthew J. Tozer. (1997). Application of 7-endo, 8-endo and 9-endo radical cyclisations to the synthesis of conformationally constrained amino acids and comparison with the corresponding Heck reactions. Chemical Communications. 637–638. 30 indexed citations

15.

Kalindjian, S. Barret, Ildiko M. Buck, Martin L. Hudson, et al.. (1996). Non-Peptide Cholecystokinin-B/Gastrin Receptor Antagonists Based on Bicyclic, Heteroaromatic Skeletons. Journal of Medicinal Chemistry. 39(9). 1806–1815. 40 indexed citations

16.

Tozer, Matthew J., et al.. (1996). Methods for the synthesis of gem-difluoromethylene compounds. Tetrahedron. 52(26). 8619–8683. 343 indexed citations

17.

Kalindjian, S. Barret, Ildiko M. Buck, Martin L. Hudson, et al.. (1995). Improving the Affinity and Selectivity of a Nonpeptide Series of Cholecystokinin-B/Gastrin Receptor Antagonists Based on the Dibenzobicyclo[2.2.2]octane Skeleton. Journal of Medicinal Chemistry. 38(21). 4294–4302. 19 indexed citations

18.

Motherwell, William B., et al.. (1993). A convenient strategy for replacement of the anomeric hydroxyl group by difluoromethyl functionality in carbohydrate derivatives. Tetrahedron. 49(36). 8087–8106. 61 indexed citations

19.

Motherwell, William B., Matthew J. Tozer, & Barry C. Ross. (1989). A convenient method for replacement of the anomeric hydroxy group in carbohydrates by difluoromethyl functionality. Journal of the Chemical Society Chemical Communications. 1437–1437. 104 indexed citations

20.

Motherwell, William B., Barry C. Ross, & Matthew J. Tozer. (1989). Some Radical Reactions of Exocyclic Carbohydrate Difluoroenol Ethers. Synlett. 1989(1). 68–70. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact